PHD Biosciences (PHD) is a New York City based biosciences company developing products for diseases with high unmet medical need. The PHD research pipeline is complimented by revenue from 16 awards that total more than $9.5 million since 2011. These include: several Small Business Innovation Research (SBIR) awards from the National Cancer Institute (NCI), and National Heart Lung and Blood Institute (NHLBI), a Small Business Technology Transfer (STTR) award from the NCI, funding from the Avon Foundation for Women, and three Center for Advanced Technology awards from New York State.
PHD DERMATOLOGY ASSETS
The PHD dermatology pipeline comprises several products that are being developed through 505(b)(2) New Drug Applications for a variety of indications. Please see the INNOVATIONS page for information.
OTC AND SKIN CARE PRODUCTS
The over the counter (OTC) drug and skin care commercial product portfolio is managed by an independent team at PHD Skin Care. Please visit www.phdskincare.com, or email email@example.com for information.